Tyrosine triple mutated AAV2-BDNF gene therapy in an inner retinal injury model induced by intravitreal injection of N–methyl-D-aspartate (NMDA)

PURPOSE: Glaucoma is a group of chronic optic neuropathies characterized by the degeneration of retinal ganglion cells (RGCs) and their axons, and they ultimately cause blindness. Because neuroprotection using neurotrophic factors against RGC loss has been proven a beneficial strategy, extensive att...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Vis
Autors principals: Shiozawa, Asaka Lee, Igarashi, Tsutomu, Kobayashi, Maika, Nakamoto, Kenji, Kameya, Shuhei, Fujishita, Shigeto, Takahashi, Hiroshi, Okada, Takashi
Format: Artigo
Idioma:Inglês
Publicat: Molecular Vision 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7300199/
https://ncbi.nlm.nih.gov/pubmed/32565669
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars